
FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys
For Immediate Release: July 25, 2025 The U.S. Food and Drug Administration is investigating the death of an 8-year-old boy who received Elevidys, a Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy. The death occurred on June 7, 2025. The …